Hemostemix (HEM) Stock Chart & Stock Price History → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free HEM Stock Alerts C$0.04 0.00 (0.00%) (As of 05/3/2024 05:24 PM ET) Add Compare Share Share ChartStock AnalysisChartHeadlinesInsider TradesStock AnalysisChartHeadlinesInsider Trades Hemostemix Stock Price Performance5 Day Performance0.00%1 Month Performance-38.46%3 Month Performance-55.56%6 Month Performance-46.67%Year-To-Date Performance-42.86%1 Year Performance-73.33% Receive HEM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. HEM Stock Chart for Saturday, May, 4, 2024 HEM Chart by TradingView Hemostemix Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/03/2024C$0.04C$0.04C$0.05C$0.0491,000 shsC$3.59 million05/02/2024C$0.04C$0.04+14.29%C$0.04C$0.0443,000 shsC$3.59 million05/01/2024C$0.04C$0.04-12.50%C$0.04C$0.0497,777 shsC$3.14 million04/30/2024C$0.04C$0.04C$0.04C$0.0457,000 shsC$3.59 million04/29/2024C$0.05C$0.04-11.11%C$0.04C$0.045,000 shsC$3.59 million04/26/2024C$0.04C$0.05+12.50%C$0.05C$0.0432,000 shsC$4.04 million Get the Latest News and Ratings for HEM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter. 04/25/2024C$0.05C$0.04-11.11%C$0.05C$0.04353,200 shsC$3.59 million04/24/2024C$0.05C$0.05-10.00%C$0.05C$0.0482,500 shsC$4.04 million04/23/2024C$0.05C$0.05C$0.05C$0.0520,000 shsC$4.49 million04/22/2024C$0.05C$0.05C$0.05C$0.0520,000 shsC$4.49 million04/19/2024C$0.05C$0.05C$0.05C$0.05111,000 shsC$4.49 million04/18/2024C$0.06C$0.05-9.09%C$0.05C$0.0516,000 shsC$4.49 million04/17/2024C$0.06C$0.06C$0.06C$0.064,200 shsC$4.94 million04/16/2024C$0.06C$0.06C$0.06C$0.0640,000 shsC$4.94 million04/15/2024C$0.06C$0.06C$0.06C$0.065,000 shsC$4.94 million04/12/2024C$0.06C$0.06C$0.06C$0.065,000 shsC$4.94 million04/11/2024C$0.06C$0.06C$0.06C$0.065,000 shsC$4.94 million04/10/2024C$0.06C$0.06-8.33%C$0.06C$0.0665,020 shsC$4.94 million04/09/2024C$0.06C$0.06C$0.06C$0.062,020 shsC$5.39 million04/08/2024C$0.06C$0.06C$0.06C$0.062,000 shsC$5.39 million04/05/2024C$0.07C$0.06-7.69%C$0.06C$0.062,000 shsC$5.39 million04/04/2024C$0.07C$0.07C$0.07C$0.0664,750 shsC$5.84 million04/03/2024C$0.07C$0.07C$0.07C$0.0664,750 shsC$5.84 million04/02/2024C$0.07C$0.07C$0.07C$0.0664,750 shsC$5.84 million04/01/2024C$0.07C$0.07C$0.07C$0.0664,750 shsC$5.84 million03/29/2024C$0.07C$0.07C$0.07C$0.0664,750 shsC$5.84 million03/28/2024C$0.07C$0.07C$0.07C$0.0664,750 shsC$5.84 million03/27/2024C$0.07C$0.07C$0.07C$0.0725,000 shsC$5.84 million03/26/2024C$0.06C$0.07+8.33%C$0.07C$0.0732,000 shsC$5.84 million03/25/2024C$0.07C$0.06-7.69%C$0.06C$0.0650,208 shsC$5.39 million03/22/2024C$0.06C$0.07+8.33%C$0.07C$0.071,000 shsC$5.84 million03/21/2024C$0.06C$0.06C$0.06C$0.0628,250 shsC$5.39 million03/20/2024C$0.08C$0.06-20.00%C$0.07C$0.05309,740 shsC$5.39 million03/19/2024C$0.08C$0.08C$0.08C$0.072,000 shsC$6.73 million03/18/2024C$0.07C$0.08+7.14%C$0.08C$0.0718,000 shsC$6.73 million03/15/2024C$0.07C$0.07C$0.07C$0.0718,000 shsC$6.29 million03/14/2024C$0.07C$0.07C$0.07C$0.0718,000 shsC$6.29 million03/13/2024C$0.08C$0.07-6.67%C$0.08C$0.0755,000 shsC$6.29 million03/12/2024C$0.07C$0.08+7.14%C$0.08C$0.0737,000 shsC$6.73 million03/11/2024C$0.08C$0.07-6.67%C$0.07C$0.0737,500 shsC$6.29 millionElon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it.03/08/2024C$0.08C$0.08-6.25%C$0.08C$0.0752,000 shsC$6.73 million03/07/2024C$0.08C$0.08C$0.09C$0.082,500 shsC$7.18 million03/06/2024C$0.08C$0.08C$0.09C$0.082,500 shsC$7.18 million03/05/2024C$0.08C$0.08C$0.09C$0.082,500 shsC$7.18 million03/04/2024C$0.08C$0.08C$0.09C$0.082,500 shsC$7.18 million03/01/2024C$0.08C$0.08C$0.08C$0.0820,000 shsC$7.18 million02/29/2024C$0.10C$0.08-15.79%C$0.08C$0.0819,036 shsC$7.18 million02/28/2024C$0.07C$0.10+35.71%C$0.10C$0.07109,333 shsC$8.53 million02/27/2024C$0.07C$0.07+7.69%C$0.07C$0.0754,000 shsC$6.29 million02/26/2024C$0.07C$0.07-7.14%C$0.08C$0.0792,000 shsC$5.84 million02/23/2024C$0.07C$0.07C$0.07C$0.0716,500 shsC$6.29 million02/22/2024C$0.08C$0.07-12.50%C$0.08C$0.0733,700 shsC$6.29 million02/21/2024C$0.08C$0.08+6.67%C$0.09C$0.0811,500 shsC$7.18 million02/20/2024C$0.08C$0.08-6.25%C$0.09C$0.0829,000 shsC$6.73 million02/19/2024C$0.08C$0.08C$0.08C$0.0831,000 shsC$7.18 million02/16/2024C$0.09C$0.08-5.88%C$0.08C$0.0831,000 shsC$7.18 million02/15/2024C$0.10C$0.09-10.53%C$0.10C$0.0922,000 shsC$7.63 million02/14/2024C$0.10C$0.10-5.00%C$0.10C$0.1014,500 shsC$8.53 million02/13/2024C$0.10C$0.10C$0.10C$0.1011,000 shsC$8.98 million02/12/2024C$0.10C$0.10C$0.11C$0.103,500 shsC$8.98 million02/09/2024C$0.11C$0.10-4.76%C$0.10C$0.1032,500 shsC$8.98 million02/08/2024C$0.10C$0.11+5.00%C$0.11C$0.108,000 shsC$9.43 million02/07/2024C$0.10C$0.10C$0.11C$0.1012,500 shsC$8.98 million02/06/2024C$0.10C$0.10+5.26%C$0.10C$0.1036,000 shsC$8.98 million02/05/2024C$0.09C$0.10+5.56%C$0.10C$0.102,000 shsC$8.53 million Related Companies: Innovotech Stock Price Chart Quest PharmaTech Stock Price Chart Aeterna Zentaris Stock Price Chart Antibe Therapeutics Stock Price Chart Resverlogix Stock Price Chart Sirona Biochem Stock Price Chart Kane Biotech Stock Price Chart Delta 9 Cannabis Stock Price Chart Entourage Health Stock Price Chart Titan Medical Stock Price Chart Receive HEM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:HEM) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryThe asset beating inflation by 4xColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemostemix Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
